Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Teva Pharmaceuticals USA Inc.
Current Parent Company: Teva Pharmaceutical Industries
Penalty: $24,000,000
Year: 2015
Date: October 21, 2015
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Teva agreed to pay $24 million to to settle litigation alleging it was part of a scheme to delay introduction of a generic version of the heartburn drug Nexium.
Level of Government: federal
Action Type: private litigation
Court: District of Massachusetts
Civil or Criminal Case: civil
Case ID: 1:12md2409
Case Name: In re: Nexium (Esomeprazole) Antitrust Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.